Galmed Pharmaceuticals Ltd. (GLMD)

CIK 1595353 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Galmed Pharmaceuticals Ltd..

Recent SEC filings

FiledFormAccession number
Sep 9, 20266-K0001493152-26-041872
Sep 8, 20266-K0001493152-26-041656
Sep 3, 2026EFFECT9999999995-26-002874
Sep 3, 20266-K0001493152-26-041357
Sep 2, 20266-K0001493152-26-041239
Sep 2, 20266-K0001493152-26-041231
Sep 2, 2026POS AM0001493152-26-041245
Aug 19, 20266-K0001493152-26-039109
Aug 19, 20266-K/A0001493152-26-039207
Aug 17, 20266-K0001493152-26-038663
Aug 14, 20266-K0001493152-26-038436
Jul 31, 20266-K0001493152-26-035621
Jul 29, 20266-K0001493152-26-035185
Jul 28, 20266-K0001493152-26-034933
Jul 22, 20266-K0001493152-26-034237
Jul 16, 20266-K0001493152-26-033451
Jul 8, 20266-K0001493152-26-032504
Jun 22, 2026424B30001493152-26-029481
Jun 22, 20266-K0001493152-26-029478
Jun 8, 2026POS EX0001493152-26-027646
Jun 8, 20266-K0001493152-26-027640
Jun 8, 2026424B30001493152-26-027645
Jun 2, 20266-K0001493152-26-026756
May 14, 20266-K0001493152-26-022873
May 6, 20266-K0001493152-26-021404